February 2003
Medical Device & Diagnostic Industry
Selected Contents
EDITOR'S
PAGE:
In Pursuit of Failure
COVER STORY
Medical Device Design: The State of the Art
Stacey L. Bell
The trends and technologies that are influencing the design of today’s medical devices reflect an increased focus on the end-user and home healthcare.
Sidebar:
Medical Devices Go Green
CORPORATE OUTLOOK
Preparing for a World of Change
Gregg Nighswonger
How are device manufacturers getting ready for technological change and new market factors? Four industry executives
share their views.
Sidebar: Roundtable
Participants
RISK MANAGEMENT
Establishing Overall Risk for Medical Devices
Mike W. Schmidt
In addition to reducing individual risks, device makers must develop an overall risk index in accordance with
ISO/IEC 14971, Clause 7.
WASHINGTON
WRAP-UP:
James G. Dickinson
McClellan Hits the Ground Running
The new FDA commissioner is demonstrating an impressive decisiveness and understanding of agency bureaucracy. A top priority is reduction of medical errors.
Plus:
- Who Reviews Combination Products?
- Bard Avoids Liability for Labeling
- Uterine Fibroids Device Cleared
- Stair-Climbing Wheelchair (pictured)
- Carbon Dioxide Monitor Guidance
- More Answers on Reprocessed Devices
NEWSTRENDS
- Robotic Surgery Litigation Offers IP Lessons, Caveats
- Health Canada Moves One Step Closer to Harmonization
- Expanded Notification of Device Recalls Urged
- ISO 13485 Splits from ISO 9000
- Mohan Assumes Key Role in IVD Firm
R&D DIGEST:
- Monitor Noninvasively Measures Premature Infants’ Vital
- Using Sound to Sterilize Medical Instruments
- Rapid Method Maps Blood Vessels in Live Tumors
- Hands-Free Medical Assistance Software Aids Emergency Treatment
Project Advisory Boards: Improving Product Development Quality and Consistency
Richard Rosen
Advisory boards enhance development efforts and help companies meet the ever-increasing challenges of developing and launching new products.
REGULATORY OUTLOOK
FDA’s Regulation of
Analyte-Specific Reagents
Jeffrey K. Shapiro and Randy J. Prebula
Confusing and at times counterintuitive, the ASR rule applies to materials used in in-house-developed tests, not the assays themselves.




